In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA, Dr. Richard T. Silver provides and update on long-acting interferons for the treatment of myeloproliferative neoplasms (MPN).
Advertisement